12:00 AM
Jul 31, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Synt:em preclinical data

Synt:em S.A., Nimes, France
Product: Pep:trans formulation of dalargin
Use: Increase uptake of compounds into the brain
Synt:em said that a formulation...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >